Direktorat Registrasi ObatValid

HYDROXYCHLOROQUINE SULFATE

by '-'

BPOM Number: GKL2009504417A1
Approved: 10 January 2025
Expiry: 8 May 2025
Form: TABLET SALUT SELAPUT

About This Registration

HYDROXYCHLOROQUINE SULFATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2009504417A1. Its current registration status is Valid, with the licence valid until 8 May 2025. The product is registered to IMEDCO DJAJA - INDONESIA. BPOM first approved this registration in May 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 3 BLISTER @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

IMEDCO DJAJA - INDONESIA
KAB. TANGERANG
NPWP: 013017579451000
owner
View profile →

Manufacturing Sites

IMEDCO DJAJA - INDONESIA
KAB. TANGERANG
primary
View profile →

Market Intelligence

Owner Portfolio: IMEDCO DJAJA - INDONESIA holds 44 BPOM registrations
Manufacturer Scale: IMEDCO DJAJA - INDONESIA produces 44 registered products
Registration Age: Registered for 6 years, 2 months
Expiry Status: Expired 436 days ago

FDA Cross-Reference

via openFDA

Generic Name: HYDROXYCHLOROQUINE SULFATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?